Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20182-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20182-1-AP, RRID:AB_10666439
- Product name
- FSTL1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated FSTL1 antibody (Cat. #20182-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival.
Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer.
Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer.
Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.
FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway.
EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis.
Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.
Apical Secretion of FSTL1 in the Respiratory Epithelium for Normal Lung Development.
Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferation.
Wu M, Ding Y, Wu N, Jiang J, Huang Y, Zhang F, Wang H, Zhou Q, Yang Y, Zhuo W, Teng L
American journal of cancer research 2021;11(3):712-728
American journal of cancer research 2021;11(3):712-728
Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer.
Naito T, Yuge R, Kitadai Y, Takigawa H, Higashi Y, Kuwai T, Kuraoka K, Tanaka S, Chayama K
Oncology reports 2021 Jun;45(6)
Oncology reports 2021 Jun;45(6)
Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer.
Ma J, Yang Y, Wang L, Jia X, Lu T, Zeng Y, Liu L, Gao Y
Aging 2021 Feb 26;13(5):7211-7227
Aging 2021 Feb 26;13(5):7211-7227
Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.
Chiou J, Chang YC, Tsai HF, Lin YF, Huang MS, Yang CJ, Hsiao M
Cancer research 2019 Dec 15;79(24):6113-6125
Cancer research 2019 Dec 15;79(24):6113-6125
FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway.
Gu C, Wang X, Long T, Wang X, Zhong Y, Ma Y, Hu Z, Li Z
Cell death & disease 2018 May 29;9(6):654
Cell death & disease 2018 May 29;9(6):654
EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis.
Sundaram GM, Ismail HM, Bashir M, Muhuri M, Vaz C, Nama S, Ow GS, Vladimirovna IA, Ramalingam R, Burke B, Tanavde V, Kuznetsov V, Lane EB, Sampath P
The Journal of experimental medicine 2017 Oct 2;214(10):2889-2900
The Journal of experimental medicine 2017 Oct 2;214(10):2889-2900
Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.
Chiou J, Su CY, Jan YH, Yang CJ, Huang MS, Yu YL, Hsiao M
Scientific reports 2017 Aug 29;7(1):9830
Scientific reports 2017 Aug 29;7(1):9830
Apical Secretion of FSTL1 in the Respiratory Epithelium for Normal Lung Development.
Li X, Fang Y, Li X, Liang J, Jiang D, Geng Y, Ning W
PloS one 2016;11(6):e0158385
PloS one 2016;11(6):e0158385
Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferation.
Chen SX, Xu XE, Wang XQ, Cui SJ, Xu LL, Jiang YH, Zhang Y, Yan HB, Zhang Q, Qiao J, Yang PY, Liu F
Journal of proteomics 2014 Oct 14;110:155-71
Journal of proteomics 2014 Oct 14;110:155-71
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- A2780 cells were subjected to SDS PAGE followed by western blot with 20182-1-AP(FSTL1 antibody) at dilution of 1:300
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FSTL1 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human FSTL1. This antibody recognizes human,mouse,rat antigen. The FSTL1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.